Professional Documents
Culture Documents
Refresher Course
z Criticality 30
z Reactors
Chernobyl + Navy 40
Sources
Medicine 35 (4 accidents)
Industry 30 (15 accidents)
Golden Rule
The Medical and Surgical Emergencies prevail over the
Radiological Emergency
Medicochirurgical Triage
Absolute Emergency
Relative Emergency
IRPA 11 Refresher Course 8
External Decontamination
(Undressing, Showering, Washing)
Tchernobyl 30 Days
BURN TREATMENT
CONTROLLED
NON LIFE THREATENING PERSON CENTER
ZONE
DECONTAMINATION
DECONTAMINATION
CHAINS
SPECIALIZED
VICTIM ASSEMBLY ADVANCED MEDICAL POST HOSPITAL
POINT EVACUATION
EXCLUSION NORIA
ZONE
2 nd TRIAGE*
RECEPTION FACILITY
PICKING
NORIA
1st TRIAGE* SUPPORT ZONE
LIFE THREATENING PERSON Clean Area
EVACUATION POINT
CLOSEST HOSPITAL
STAFF
EXIT AIRLOCK
STAFF WIND DIRECTION
MARKING AREA ENTRANCE AIRLOCK
IRPA 11 Refresher Course 10
The Scenarios in Terms of Health Consequences
EVENT SCENARIO INSIDIOUS SCENARIO
0,5 50 25 4
1 12,5 6 8
2 3 1,5 16
25
Acute phase
Severity
10
5
)
( Gy
Latency period
3
se
Do
1,5
0,5
2 15 30 2 4 6 12 2 3 4 5 6 2 3 4 5 6
minutes hours days weeks
Headache
Hyperthermia
Hypotension
Cognitive deficits Transient Incapacitation Syndrome
Permanant Incapacitation Syndrome
Erythema
IRPA 11 Refresher Course 14
The Prodromal Phase of the ARS
Anorexia, Nausea, Emesis
3000
Normal range
Absolute lymphocyte count
2000
Moderate
1000
Severe Radiation
injury
500
Very severe
100
0 Lethal
0 24 48
Days
IRPA 11 from
Refresher Course 17
(Adapted Andrews, 1980)
The Acute Radiation Syndrome (ARS)
Initial phase
25
Acute phase
Severity
10
5
)
( Gy
Latency period
3
se
Do
1,5
0,5
2 15 30 2 4 6 12 2 3 4 5 6 2 3 4 5 6
minutes hours days weeks
Cerebrovascular
10
Syndrome
1
1 10 100 1000
Dose (Gy)
IRPA 11VP
( Bond Refresher
et al, 1965,Course 19
In: Mammalian Radiation Lethality, pp 231-275 ).
The Acute Radiation Syndrome
Whole-body Irradiation
12 Gy
BONE MARROW
THERAPEUTIC
GASTROINTESTINAL
1 Gy ACTION
30 Gy
SUBCLINICAL
CEREBROVASCULAR
INCREASING DOSE
IRPA 11 Refresher Course 20
The Hematopoietic Syndrome
The Compartmentalisation of Hematopoiesis
Proliferating
Differentiating
Resting compartment: Mature
compartment: BLOOD
Stem Stem Cell and Cells
Precursors
Cells Progenitors
Proliferation,
Activation Differentiation Exit
Differentiation
Block of
Depletion by
Proliferation, Blood Aplasia
lack of
Cell Death
Renewal
IRPA 11 Refresher Course 21
Survival Curve for CFU-S
IRPA 11 Refresher Course 22 ( Hall E.J. Radiobiology for the Radiologist, 2000 )
Peripheral Blood Aplasia
3 Gy
5 Gy
10 Gy
RX 4 MV
50 Gy
60Co
137Cs
Neutrons RX
fission 230 kV
Estimated mean dose to bone
marrow: 5 Gy.
But 16% of bone marrow received
less that 1 Gy. 25
IRPA 11 Refresher Course
Chimerism after Cord Blood Transplantation
Toka Mura Accident
Case Selection :
z Autologus or syngenic Hematopoietic SCT
z Narrow Dose Therapeutic Window :
Lethal Marrow Injury without Lethal Injury to other organs (<10 Gy)
Control 16 Gy Day 5
Fluid and Electrolyte Loss
Endotoxemia, Bacteremia
> 50 Gy
Permament Incapacitation Syndrome
Disorientation
Confusion
Prostration
Ataxia
Seizures
Absence Deep tendon and Corneal Reflexes
Hyperthermia
Respiratory Distress
Cardiovascular Shock
Death within 2 days
BM
GUT
CNS
1 5 10 20 50
Dose (in Gy) Morphological manifestations (lesions)
Syndrome
hematopoietic
gastrointestinal
Cerebro-vasc.
Funtional manifestations
hematopoietic
System
gastrointestinal
cerebro-vasc.
IRPA 11 Refresher Course 32
Multiple Organ Dysfunction Syndrome (MODS)
Toka-Mura Accident
Diarrhoea GI bleeding
Gastrointestinal
disease
Kidney
dysfunction
Liver
dysfunction
1 2 3 4 5 6 7 8 9 10 11 death
Time after irradiation (weeks)
IRRADIATION
IRPA 11 Refresher Course 33
The New Concept :
Multiple Organ Dysfunction Syndrome (MODS)
Multiple Organ Failure (MOF)
SKIN
CNS
LUNG
High-dose
Radiation
Bleeding
Sepsis
Endothelial Disturbance in
Cell Damage Microcirculation
Parenchymal
Cell Damage
(From Dr Makoto Akashi) (Loss of electrolytes)
IRPA 11 Refresher Course 35
TYPE OF PARTICLE
MULTIPLE ORGAN
DYSFUNCTION SYNDROME (MODS)
N = neurovascular system
H = haematopoietic system
C = cutaneous system
G = gastrointestinal system
Lymphocyte > 1.5 x 109 1-1.5 x 109 0.5-1 x 109 < 0.5 x 109 1.4-3.5 x 109
changes cells/L cells/L cells/L cells/L cells/L
Granulocyte > 2 x 109 1-2 x 109 0.5-1 x 109 < 0.5 x 109 4-9 x 109
changes cells/L cells/L l cells/L cells/L cells/L2.
Thrombocyte > 100 x 109 50-100x109 20-50x 109 < 20 x 109 140-400x109
changes cells/L l cells/L cells/L cells/L cells/L3
GRADING CODE : N i H i C i G i
Hi
1 2 3 4
Hospitalization
ICU ICU
Ambulatory
Monitoring Blood Component Blood Component Blood Component
Transfusion Transfusion Transfusion
RC 1 RC 2 RC 3 RC 4
Degree of
damage Mild Moderate Severe Serious/Fatal
Three Layers :
z Epidermis ( Hierarchical Tissue )
z Dermis ( Flexible )
z Hypodermis ( Flexible )
Acute Phases
Late Phase
Late Effects
2 Weeks
Neoderma Formation
Unmeshed Autograft
Final Aspect
Chronic Reactions
z Social withdrawal, Impaired Concentration, Insomnia, Chronic Anxiety
z Deterioration in Quality of Life
z Post Traumatic Stress Disorder
Available now:
Granulocyte colony-stimulating factor (G-CSF)
Granulocyte-macrophage colony-stimulating factor (GM-CSF)
Pegylated G-CSF (Peg-G-CSF)
Future?
Single cytokine treatment
Interleukin- 7 (IL-7)
Keratinocyte growth factor (KGF)
flt-3 (FL)
Thrombopoietin (TPO)
IRPA 11 Refresher Course 57